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ABSTRACT We have used oligonucleotide-directed mutagen-
esis to make a specific change in the f-lactamase (EC 3.5.2.6)
(ampicillin resistance) gene of the plasmid pBR322. Evidence sug-
gests that the active site for this enzyme may include a serine-thre-
onine dyad (residues 70 and 71). By priming in vitro DNA synthesis
with a chemically synthesized 16-base oligodeoxyribonucleotide,
we have inverted the Ser-Thr dyad to Thr-Ser and thereby gen-
erated a mutant with an ampicillin-sensitive phenotype. This "dou-
ble-mismatch" method is relatively simple and also very general
because detection of mutants is at the level of DNA and involves
only colony hybridization. Accordingly, the procedure can be ap-
plied to anyDNA sequence and does not depend on the phenotype
of the mutant.
Rational study of the influence of amino acid sequence on the
three-dimensional structure and function of a protein would
benefit greatly from the ability to change specific residues.
When the gene for the protein has been cloned and is expressed
in an appropriate vector, site-directed mutagenesis (1, 2) pro-
vides a method for creating new proteins whose structural and
functional characteristics may be of practical value or may offer
significant mechanistic insights.
Oligonucleotide-directed mutagenesis, the most specific
form ofdirected mutagenesis, has been used to produce specific
base changes in the single-stranded phage 4X174 (3, 4). The
method (Fig. 1) involves priming in vitro DNA synthesis with
a chemically synthesized oligodeoxynucleotide that carries at
least a single base mismatch with the complementary strand of
the "wild-type" DNA. Because DNA polymerases require a
double-stranded segment for initiation of DNA replication, the
synthetic oligodeoxynucleotide primes DNA synthesis and is,
itself, incorporated into the resulting heteroduplex molecule.
After molecular cloning, semiconservative in vivo replication
of this heteroduplex gives rise to homoduplexes whose se-
quences are either that of the original wild-type DNA or that
of the synthetic oligodeoxynucleotide. With single-stranded
circular DNAs, priming with oligodeoxynucleotides has been
used to cause transitions, transversions, and deletions, in some
cases very efficiently (5-11). Wallace et aL (12, 13) have ex-
tended the technique to double-stranded circular DNAs, and
even though the frequency of directed mutagenesis may be
lower, screening of colonies with the 32P-labeled synthetic oli-
godeoxynucleotide allows easy detection of the desired mutant
(12, 13).
The particular virtue of oligonucleotide-directed mutagene-
sis for structure-function studies lies in allowing one to produce
mutant proteins with very specific changes in particular resi-
dues, which, for example, may be directly involved in catalysis
or in determining substrate specificity. In this way, one can test
ideas about the roles ofparticular amino acid side chains. Other
procedures are valuable for producing random or less specific
changes as, for example, in the creation of a mutant of f3lac-
tamase (EC 3.5.2.6) with enhanced activity toward cephalospo-
rins (14). Interesting mutants of ,f3lactamase have also been
generated by segment-directed mutagenesis (15, 16) or by mis-
repair of gaps placed at restriction sites (17).
f3-Lactamase provides a particularly favorable system for de-
veloping the technique ofoligonucleotide-directed mutagenesis
and for demonstrating the general feasibility of this approach
to the study of protein function. The gene for 83-lactamase is
contained in the common double-stranded cloning vehicle plas-
mid pBR322, which has a total ofonly 4,362 base pairs and which
contains a second selectable marker for resistance to tetracy-
cline (18). The complete nucleotide sequence ofthe -3-lactamase
gene has been determined (19), and when pBR322 is grown in
Escherichia coli, the enzyme is expressed and secreted into the
periplasmic space, from which it can be readily isolated (20).
,B3Lactamase catalyzes the hydrolysis of the amide bond of
the lactam ring ofpenicillins and related antibiotics; the catalytic
pathway includes an acyl-enzyme intermediate (20). A serine
residue probably participates in catalysis (21-26) and is part of
a conserved Ser-Thr dyad (26). [These residues have been num-
bered Ser-70 and Thr-71 (26).] Presumably the hydroxyl group
of Ser-70 adds nucleophilically to the carbonyl group of the (-
lactamf ring in a mechanism somewhat analogous to that ofserine
proteases. The role of Thr-71 is less clear, but it seems essential
for catalytic activity because a mutant, probably with isoleucine
at this position, shows no catalytic activity (26).
In this work, whose main focus was on the procedures for
generating and identifying site-specific mutants, we used a dou-
ble-mismatch method to invert the order ofthe dyad from Ser-
Thr to Thr-Ser (i.e., a double mutation: Ser-70 -- Thr and Thr-
71 -- Ser). The mutant bacteria show no /&lactamase activity,
which suggests a functional defect in the mutant enzyme.
MATERIALS AND METHODS
DNAs and Transformation. Plasmid pBR322 (18) was grown
in E. coli strain LS1 (pro, leu, thi, rpsL20, hsdR, hsdM, ara-14,
galK2, xyl-5, mtlA, supE44), a derivative ofHB101 (27). Plasmid
DNA was prepared according to the method of Birnboim and
Doly (28) and supercoils were further purified by chromatog-
raphy on acridine yellow ED gel (Boehringer Mannheim) as
Abbreviations: NaCl/EDTA/Tris, 0.15 M NaCl/1 mM EDTA/0.03 M
Tris'HCl, pH 8.0; NaCl/Cit, 0.15 M NaCl/0.015 M sodium citrate, pH
7.0.
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FIG. 1. Overall scheme for oligonucleotide-directed mutagenesis of double-stranded circular plasmid DNA. Supercoiled plasmid circles are
nicked in one strand and rendered partially single-stranded by treatment with exonuclease. The gapped circles are hybridized with a homologous
oligodeoxynucleotide carrying, by design, some mismatches. In vitro DNA synthesis, primed in part by the oligodeoxynucleotide, leads to hetero-
duplex plasmid circles. Molecular cloning and in vivo DNA replication generates homoduplexes, some of which have theDNA sequence of the primer
oligodeoxynucleotide. Colony screening, with the same oligodeoxynucleotide labeled with 32P as a hybridization probe, allows identification of the
desired mutant colony regardless of its phenotype.
described by Vincent and Goldstein (29) or, alternatively, by
ethidium bromide centrifugation followed by gel filtration (30).
It probably is important that the plasmid DNA be free of oh-
godeoxynucleotides that often contaminate DNA preparations.
For secondary transformations, where in vitro DNA synthesis
is not involved, the rapid plasmid DNA isolation procedure of
Ish-Horowicz and Burke (31) is convenient. Competent cells
were prepared and transformations were done according to
Hanahan (32). Selection was for resistance to tetracycline at 20
kg/ml.
The 16-base oligodeoxynucleotide 5'-A-A-T-G-A-T-G-A-C-
C-T-C-T-T-T-T-3' was synthesized from dinucleotides by the
triester method on a solid-phase support (33).
Enzymes. E. coli exonuclease III, E. coli DNA polymerase
1 (large fragment), phage T4 ligase, and the restriction enzyme
Hpa II were obtained from Bethesda Research Laboratories.
T4 polynucleotide kinase was obtained from Boehringer Mann-
heim.
Preparation of Nicked DNA. Fifteen micrograms of pure
supercoiled pBR322 DNA and 9.0 ttg of ethidium bromide in
150 ,ul of 20 mM Tris-HCl, pH 7.4/1 mM dithiothreitol/7 mM
MgCl2 were treated in the dark at room temperature with 7.5
units ofHpa II for a time estimated to produce about 75% nicked
circles and 25% linear molecules (about 1 hr). The time and
concentrations should be determined empirically on a smaller
scale with the same reagents. The reaction was assayed by elec-
trophoresis on 1.2% agarose in 40 mM Tris acetate, pH 7.8/
10 mM EDTA (conditions that separate linear, circular, and
supercoiled DNA molecules). We used Hpa II for nicking be-
cause 52 Hpa II sites are in pBR322 (one ofthem is near the Ser-
70 region). Moreover, Hpa II is appropriately inhibited by
ethidium bromide, in contrast to some other restriction en-
zymes (e.g., Pst I). DNase 1 could also have been used (13),
because the precise location of the nick probably is not critical.
The reaction was stopped by adding 0.1 vol of 0.1 M EDTA
and the solution was extracted twice with phenol, once with
chloroform, and then twice with diethyl ether. These extrac-
tions removed both protein and ethidium bromide. The DNA
was precipitated by adding 0.1 vol of 3 M ammonium acetate
and 2 vol of ethanol. After centrifugation, the pellet was washed
with 70% (vol/vol) ethanol, dried, and dissolved in 15 AI of ster-
ile water.
Exonuclease Treatment, Heteroduplex Formation, and
Transformation. About 1 jig (0.4 pmol) ofthe nicked DNA was
treated for 15 min at room temperature with 6 units of E. coli
exonuclease III in 50 mM Tris-HCI, pH 8.0/5 mM MgCl2/10
mM 2-mercaptoethanol (total volume, 3 sul). The enzyme was
inactivated by heating to 60TC in the presence of chloroform,
which was then removed by evaporation under reduced pres-
sure. The nicked and exonuclease-treated DNA was heated to
65TC for 5 min in 0.5 M NaCl in the presence of 80 ng of the
synthetic oligonucleotide (18 pmol) in a 5-1.l volume and al-
lowed to stand at room temperature for 1 hr.
Buffer and salt concentrations were adjusted to 100 mM
NaCl, 20mM Tris-HCI at pH 7.5, 10 mM dithiothreitol, 10mM
MgCl2, each ofthe four deoxynucleoside triphosphates at about
400 ,uM, and 500 AM ATP. Sixteen units of E. coli DNA poly-
merase I (large fragment) and 40 units of T4 DNA ligase were
added to yield a final reaction volume of50 ,ul. Four microliters
of this reaction mixture was used directly to transform com-
petent E. coli LS1. A second cycle oftransformation was usually
done after a quick plasmid preparation (31) from an overnight
10-ml broth culture containing tetracycline at 20 ,g/ml and
inoculated with the original transformation mix.
Colony Screening by Primer-Probe Hybridization. Gergen
et aL (34) described a microtiter dish colony collection proce-
dure and a procedure for making filter paper replicas of the
colony collection. By following this procedure, a colony collec-
tion was made, transferred to agar with a 96-prong replicator,
and grown for 18 hr. The colonies were "lifted" onto Whatman
541 filter paper for amplification on 250/,g/ml chloramphen-
icol plates for 24 hr, followed by alkali lysis and neutralization
(34). The filters prepared in this way were then prehybridized
for 3 hr at 65°C in 6X NaCl/EDTA/Tris, 0.5% Nonidet P-40,
and denatured, sonicated salmon sperm DNA at 100 ,g/ml
(lx NaCl/EDTA/Tris is 0.15 M NaCl/1 mM EDTA/0.03 M
Tris-HC1, pH 8.0). Hybridization with 32P-labeled oligonucleo-
tide was done at room temperature for 16-18 hr in 6X NaCl/
EDTA/Tris, 0.5% Nonidet P-40, 250 ,ug of yeast tRNA per
ml, and 1.6 ng of 32P-labeled oligodeoxynucleotide per ml (at
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FIG. 2. Nucleotide sequence of the synthetic oligodeoxynucleotide
used as a specific mutagen and of the complementary wild-type strand.
The amino acids encoded by both mutant and wild-type sequences are
shown. nt NO is the nucleotide number in pBR322 (19). aa NO is the
amino acid number in 3-lactamase (26).
least 107 cpm/tug). The filters were washed three times in 25-
50 ml per filter of6x NaCl/Cit (1 x NaCl/Cit is 0.15 M NaCI/
0.015 M sodium citrate, pH 7.0) for 5 min at room temperature
and autoradiographed. The temperature of the hybridization
and washing is important and will vary with the nucleotide se-
quence and length. We have followed empirical rules devel-
oped by Suggs et al (35) for oligodeoxynucleotide hybridizations
on Southern blots and colony screens. One estimates the ap-
parent melting point (td) to be the sum of 20C per A-T base pair
and 40C for each G-C base pair when the hybridizations and
washes are done in 6x NaCl/EDTA/Tris or 6x NaCl/Cit. We
do the hybridizations at least 5YC below the calculated td and
do a series ofwashes and autoradiography, first at SoC and then
at higher temperatures to ensure passing through the temper-
ature that best distinguishes mutant from wild type.
RESULTS
Fig. 1 illustrates our use of a 16-base synthetic oligodeoxynu-
cleotide with two Deliberate base pair mismatches to prime in
vitro DNA synthesis on pBR322 DNA containing single-
stranded regions that had been generated by exonuclease treat-
ment of nicked, double-stranded circles. The two mismatches
in the primer d(A-A-T-G-A-T-G-A-C-C-T-C-T-T-T-T) at the bases
denoted (*) will accomplish the double mutation Ser-70 -- Thr
and Thr-71 -- Ser (Fig. 2). For generality, the method is de-
signed for screening at the DNA level rather than depending
on the phenotype of the mutant protein. Therefore, we have
used colony hybridization with a 32P-labeled oligodeoxynucleo-
tide to select mutants. Conveniently, the same oligodeoxynu-
cleotide used as a primer in the in vitro synthesis can be labeled
with 32P and also used as a hybridization probe. Those colonies
containing the mutant gene will match perfectly with the syn-
thetic probe and therefore hybridize more strongly than will
wild-type colonies, which have two base pair mismatches.
Fig. 3 shows the result of a colony screen; a mutant can be
clearly identified. In this experiment, colonies were picked and
distributed into microtiter dishes to provide an ordered array
and a permanent library (34). After growth, a filter replica of
the colonies was made and used for colony screening (13, 34).
The microtiter dish technique allowed convenient screening
of a few thousand colonies and was used to isolate the first mu-
tant (22G9). However, when it became apparent that the fre-
quency of the desired mutation was only about one in a thou-
sand, we began to use a random colony screening procedure,
which allows the rapid evaluation of tens of thousands of colo-
nies. Fig. 4 shows the results ofsuch a screen: the bottom shows
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FIG. 3. Autoradiogram showing the result of a colony screen. Col-
onies from a second transformation (see Fig. 1) were picked and grown
in a microtiter dish to provide a convenient permanent library. Filter
paper replicas of the library, prepared as described in text and ref. 34,
were hybridized with the 32P-labeled oligodeoxynucleotide, washed,
and autoradiographed. The darkest colony, designated 22G9, proved
to be the desired mutant.
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FIG. 4. Autoradiogram showing the results of a colony screen of
randomly spread colonies. The upper circle shows cells from a second
transformation spread randomly on the surface of 15-cm L agar plates.
About 2,000 tetracycline-sensitive colonies were expected from prelim-
inary experiments. After overnight growth, when the colonies were
about 1mm in diameter, they were transferred to 541 filter papers and
then treated as described in the text and ref. 34. The lower circle is a
control of randomly spread cells containing a perfect match (mutant
22G9), grown and treated as described above.
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FIG. 5. Hybridization of 32P-labeled oligodeoxynucleotide with gel-purified plasmid DNAs. Plasmid DNAs, prepared from 7-ml overnight un-
amplified cultures as described by Ish-Horowicz and Burke (31), were each digested with EcoRI in a reaction volume of 65 ,Al. Aliquots were elec-
trophoresed in 1.2% agarose. The gel was stained with ethidium bromide and photographed. Then it was treated for 20 min at room temperature
with 0.15 M NaCl and 0.5 M NaOH and neutralized in 0.15 M NaCl and 0.5 M Tris HCl, pH 7.4. The gel was dried in a gel dryer (Bio-Rad) and the
resulting membrane was hybridized overnight at room temperature in 6x NaCl/EDTA/Tris, 0.5% Nonidet P-40, 250 ,Ag of tRNA per ml, and 1.6
ng of 32P-labeled oligodeoxynucleotide per ml. No prehybridization is necessary. The gel membrane was then washed three times for 10 min each
at 40C in 6x NaCl/Cit followed by three washes for 5 min each at 370C in 6x NaCl/Cit. (a) Ethidium bromide-stained gel. Lane 1, 0.4 ,Ag of pBR322
standard; lanes 2-5, 0.1, 0.2, 0.5, and 1.0 ,ug of EcoRI-cut pBR322; lanes 6 and 7, 10 and 30 ,A of EcoRI digest of clone 38G3, respectively; lanes
8 and 9, 10 and 30 1l of EcoRI digest of clone 22G9, respectively. (b) Autoradiogram of the dried gel after hybridization.
a control with random colonies of a known perfect match (mu-
tant 22G9); the top shows a similar screening of about 1,800
colonies resulting from an independent in vitro mutagenesis
experiment. Wild-type colonies do give a weak signal, but mu-
tants, two of which can be seen, stand out clearly. The back-
ground and positive signal is somewhat variable, and, for this
reason, oligodeoxynucleotides of at least 15 bases probably
should be used for this type of screening, even though shorter
oligodeoxynucleotides may serve for the priming step and for
Southern blotting (7, 8). A 19-base probe gives a very strong and
reliable signal (13). Differences of two bases between mutant
and wild-type greatly increase the ability to identify mutants
unambiguously, even though, in most cases, single-base mis-
matches probably can be identified (13).
Even with the double-mismatch method used in this work,
false positives occasionally were observed, especially when
unordered colonies were screened. Random dark spots, prob-
ably from [32P]ATP or [32P]orthophosphate, also occur and often
cannot be clearly distinguished from mutant colonies. The num-
ber of these spots can be reduced significantly by filtering the
solution for hybridization just before use; nevertheless, a second
screening of plasmid DNA from a putative mutant is essential.
Fortunately, this can be accomplished easily by a rapid prep-
aration ofDNA (31) followed by agarose gel electrophoresis and
hybridization (36). The standard Southern transfer to nitrocel-
lulose (36) can be used, but we have found it even more con-
venient to simply dry the agarose gel and use the resulting agar-
ose membrane directly for hybridization with the 32P-labeled
oligodeoxynucleotide (S. G. S. Tsao, C. F. Brunk, and R. Pearl-
man; personal communication). Fig. 5 illustrates the unambig-
uous discrimination between wild-type and mutant colonies.
This analysis also discriminates single base mismatches (ref. 13
and unpublished data) and should show differences between
single- and double-base mismatches, possibly because any such
mutants were not picked at the earlier colony screening step
(the faint colony in Fig. 3 has not yet been analyzed).
To show that the expected two-base change has actually been
made, the sequence of the DNA in the region of the active site
(Ser-70 and Thr-71) has been determined by the Maxam-Gilbert
technique (37) and the sequence in one strand has been con-
firmed by the dideoxy method (38) after subcloning in M 13mp7.
Although mutant colonies can be identified by colony hy-
bridization after the first transformation with heteroduplex plas-
mid DNA, these colonies probably contain a mixture of wild-
type and mutant plasmids because the colonies grow in ampi-
cillin. After a rapid preparation of plasmid from these "mixed"
colonies and a second transformation, 30-50% of the resulting
colonies hybridize strongly to the 32P-labeled oligodeoxynu-
cleotide; all of these are sensitive to ampicillin.
We have obtained mutants in three independent repetitions
of the procedure. All show similar characteristics of hybridiza-
tion and ampicillin sensitivity. Several thousand apparently
wild-type colonies also were screened and all of these were re-
sistant to ampicillin. Thus, the procedure does not produce, at
a detectable frequency, random mutants that have functionally
inactive ,3-lactamase. A fortuitous connection between the dem-
onstrated DNA sequence changes in the mutants and the am-
picillin-sensitive phenotype seems remote.
DISCUSSION
The procedure described here reproducibly yields mutants that
hybridize much more strongly than wild-type colonies with the
synthetic oligodeoxynucleotide probe that is used first as the
primer for in vitro synthesis of heteroduplex plasmid and then
as a probe for identifying mutants. The plasmid DNA of one
mutant has been characterized in the region ofthe mutation and
shown to have the desired sequence.
All of the mutants that show strong hybridization with the
synthetic probe are also sensitive to ampicillin. The inversion
Proc. Nad Acad. Sci. USA 79 (1982)
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of Ser-Thr to Thr-Ser was expected to affect catalytic activity
because, for example, the substitution of the primary alcohol
ofSer-70 bythe secondary alcohol of Thr might sterically hinder
nucleophilic attack by the hydroxyl group; the amino acid
changes also might cause conformational rearrangement within
,the active site. Particularly interesting in this respect will be
studies on the ability of the mutant protein to bind penicillins
and related substrates, as distinct from its ability to act as a cata-
lyst. Also ofinterest will be the effects ofthe single changes Ser-
70 --'Thr and Thr-71 -+ Ser. These mutants might have arisen
by partial repair during the mutagenesis procedure, but so far
we have isolated no such single-base-change mutants. Although
preliminary studies on cell extracts suggest that the mutant
protein is catalyticully inactive, other. reasons for the. absence
of ampicillin resistance, such as more rapid proteolytic degra-
dation of the mutant protein, remain a formal possibility.
The present yield of mutants, about one per thousand, should
be raised significantly by. further improvements.. However, a
major point is that improvements are not required because of
the rapidity and reliability ofthe screening procedure (13). The
screening procedure depends only on DNA sequence and not
on any phenotypic difference between mutant and wild type.
This feature allows easy detection of mutants even with phe-
notypically silent changes. For example, even though the Ser-
70 -* Thr and Thr-71 -- Ser mutant of 13-lactamase created in
this work is functionally-inactive, one could as easily have iden-
tified a mutant that retains normal activity, has acquired en-
hanced catalytic effectiveness, or displays altered specificities
for various substrates. The use of double-base mismatches to
facilitate identification ofmutants, even when-one ofthese-base
changes causes no amino.acid change, should be emphasized.
The degeneracy ofthe genetic code makes the double-mismatch
approach applicable even for single amino acid changes. These
features of the method, together with the ability to create spe-
cific mutations at-any region of the genome, should. encourage
its widespread application.
The generation of a specifically restructured mutant protein
generally will require six steps: (i) cloning of the relevant gene
in an appropriate vector, (ii) expression of the cloned gene, (iii)
determination of'the DNA sequence of the gene, (iv) chemical
synthesis -of an oligodeoxynucleotide, (v) oligonucleotide-di-
rected in vitro mutagenesis, and (vi) identification of mutant
colonies. This.work has focused on steps v and vi, which,. to-
gether with present and rapidly improving techniques for ac-
complishing steps i-iv, should allow the restructuring of pro-
teins to become a common undertaking and thereby increase
our understanding of the relationship between primary struc-
ture and biological function. Moreover,. such techniques also
will allow, the synthesis of new proteins with useful properties
not hitherto available.
Note Added in Proof. Using this technique, we have generated a one-
base mutant, Ser-70 -* Thr [d(... A-T-G-A-T-G-A-C-C-A-C-T...)],
which is catalytically inactive. We have also obtained Thr-71 -+ Ser
[d(... .A-T-G-A-T-G-A-G-C-T-C-T... .)], which has alow level ofactivity.
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